Circular Genomics, Inc. specializes in circular RNA diagnostics and research for psychiatric and neurological conditions.
Subscribe to see Circular Genomics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Circular Genomics Inc. is a healthcare technology company headquartered in Albuquerque, United States. Its most recent funding round, Series A, raised $15M in December 2025. Xcout tracks 8 named people at Circular Genomics Inc., including Paul Sargeant (President and Chief Executive Officer, Member of Board of Directors).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Circular Genomics Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | 5 named | |
| Series A | $8.3M | 4 named | |
| SEC Form D filing | $3.1M | — | |
| Seed | $4.5M | — | |
| SEC Form D filing | $1.2M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 4 named investors across 3 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Circular Genomics Inc.'s closest competitors — see the full list of competitors and alternatives →
Genetika Plus (now known as NeuroKaire) focuses on transforming depression medication selection by addressing conditions like depression affecting millions worldwide, and collaborates on biopharma trials.
RESVO Inc. is a Japanese biotechnology and medical research company with locations in Kanagawa, Fukushima, and Hyogo. The startup develops blood test kits and biomarkers for psychiatric conditions such as schizophrenia and autism.
AssureRx Health was a personalized-medicine company that developed GeneSight, a pharmacogenomic test intended to help healthcare providers select and dose psychiatric medications based on a patient’s genetic profile. It served clinicians and patients in behavioral health and was acquired by Myriad Genetics in 2016, becoming part of Myriad’s neuroscience business.
Genomind, Inc. is a healthcare company located in King of Prussia, Pennsylvania, that helps medical providers make better prescribing decisions based on a patient's genetics.
LineaGen, Inc. is a genetic testing and research company that provides advanced neurodevelopmental diagnostic evaluations. The company has conducted large-scale studies focused on genetic variants and operates as a part of Bionano Laboratories.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Circular Genomics Inc.? Suggest a correction · Work at Circular Genomics Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.